Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04

Journal of Clinical Oncology

Volumn 30, Issue 31, 2012, Pages 3827-3833

  Ngan, Samuel Y ^a,i   Burmeister, Bryan ^c   Fisher, Richard J ^a,i   Solomon, Michael ^d,l   Goldstein, David ^e,j   Joseph, David ^f   Ackland, Stephen P ^g,k   Schache, David ^c   McClure, Bev ^a   McLachlan, Sue Anne ^a,b,i   McKendrick, Joseph ^h,m   Leong, Trevor ^a,i   Hartopeanu, Cris ⁿ   Zalcberg, John ^a,i   Mackay, John ^a,i  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e PRINCE OF WALES HOSPITAL   (Australia)

^f SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^g CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^h BOX HILL HOSPITAL   (Australia)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j UNIVERSITY OF NEW SOUTH WALES   (Australia)

^k UNIVERSITY OF NEWCASTLE   (Australia)

^l UNIVERSITY OF SYDNEY   (Australia)

^m MONASH UNIVERSITY   (Australia)

ⁿ WAIKATO HOSPITAL   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; AUSTRALIA; BLADDER INJURY; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COMPARATIVE EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HUMAN; INTESTINE INJURY; LONG COURSE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEW ZEALAND; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RECTUM CARCINOMA; RECURRENCE FREE SURVIVAL; RISK REDUCTION; SHORT COURSE THERAPY; SKIN TOXICITY; TREATMENT DURATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 84869108068     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.42.9597     Document Type: Article

References (18)

1. Cammà C, Giunta M, Fiorica F, et al: Preoperative radiotherapy for respectable rectal cancer: A meta-analysis. JAMA 284:1008-1015, 2000 (Pubitemid 30659131)
2. Colorectal Cancer Collaborative Group: Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet 358:1291-1304, 2001
3. Folkesson J, Birgisson H, Pahlman L, et al: Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23:5644-5650, 2005
4. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646, 2001
5. Sebag-Montefiore D, Stephens RJ, Steele R, et al: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC CTG C016): A multicentre, randomised trial. Lancet 373:811-820, 2009
6. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004
7. Gérard JP, Azria D, Gourgou-Bourgade S, et al: Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 28:1638-1644, 2010
8. Aschele C, Cionini L, Lonardi S, et al: Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: Pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 29:2773-2780, 2011
9. Clinical Oncological Society of Australia and Australian Cancer Network: Elective surgery for rectal cancer, in NHMRC Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. Commonwealth of Australia, 1999, pp 93-109
10. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346, 1995
11. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980-987, 1997
12. Ngan SY, Fisher R, Burmeister BH, et al: Promising results of a cooperative group phase II trial of preoperative chemoradiation for locally advanced rectal cancer (TROG 9801). Dis Colon Rectum 48:1389-1396, 2005 (Pubitemid 40933866)
13. Schafer JL: Analysis of Incomplete Multivariate Data. Chapman & Hall, PennUSA, 1996
14. Kusters M, Marijnen CA, van de Velde CJ, et al: Patterns of local recurrence in rectal cancer: A study of the Dutch TME trial. Eur J Surg Oncol 36:470-476, 2010
15. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al: Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72:15-24, 2004 (Pubitemid 38952855)
16. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al: Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215-1223, 2006 (Pubitemid 44547018)
17. Pettersson D, Cedermark B, Holm T, et al: Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 97:580-587, 2010
18. Frykholm GJ, Sintorn K, Montelius A, et al: Acute lumbosacral plexopathy during and after preoperative radiotherapy of rectal adenocarcinoma. Radiother Oncol 38:121-130, 1996 (Pubitemid 26061033)